Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05351255 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 19, 2023 to Dec 19, 2026
    • Trial status: Completed to Active, Not Recruiting
    • Enrollment target: 12 to 17
    v8
  2. Trial status: Active, Not Recruiting to Completed
    • Primary completion date changed from estimate of Aug 31, 2024 to Dec 19, 2023
    • Study completion date changed from estimate of Aug 30, 2025 to Dec 19, 2023
    v7
  3. Primary completion date: Aug 31, 2023 to Aug 31, 2024
    • Study completion date: Aug 30, 2024 to Aug 30, 2025
    v6
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  5. Primary completion date: Apr 30, 2023 to Aug 31, 2023
    • Study completion date: Apr 30, 2024 to Aug 30, 2024
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2022 to Jul 1, 2022
    • Site details revised
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will determine (1) whether baseline inhibitory activity in the primary motor cortex can predict motor learning ability in individuals with cerebellar degeneration, and (2) whether modulating primary motor cortex activity with non-invasive brain stimulation alters motor learning ability in this population.
Trial Details
NCT Number NCT05351255
Lead Sponsor Albert Einstein Healthcare Network
Collaborators: Medical University of South Carolina
Conditions
(from sponsor)		 Cerebellar Ataxia
Related terms Cerebellar Ataxia
Enrollment 17 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov